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a b s t r a c t
The Heidenhain form of Creutzfeldt–Jakob disease (CJD) is a rare CJD variant with predomi-
nantly visual symptoms in the early stages. Clinical manifestations of metamorphopsia,
hemianopia and Balint's syndrome correlate with the involvement of the posterior cortical
regions. A 71-year old healthy and very active man was admitted because of impaired visual
acuity, hemianopia, and gait disturbance progressing over one week. MRI found typical
cortical hyperintensities in the occipital regions while rhythm slowing and sharp waves
were seen in the occipital regions on EEG. Protein 14-3-3 was detected in the cerebrospinal
ﬂuid. Postmortem neuropathology revealed typical histopathological changes consistent
with CJD. Moreover, we found deposits of phosphorylated tau protein in the limbic regions
that met the criteria for primary age-related tauopathy (PART); representing an additional
and interesting ﬁnding in our case.
© 2017 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.
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Creutzfeldt–Jakob disease (CJD), the most common human
prion disease, is a rare degenerative and invariably fatal brain
disorder. Currently, four forms of the disease have been* Corresponding author at: Department of Neurology, Regional Hospital 
532 03 Pardubice, Czech Republic. Tel.: +420 466014701.
http://dx.doi.org/10.1016/j.pjnns.2017.01.011
0028-3843/© 2017 Polish Neurological Society. Published by Elsevier Sidentiﬁed: sporadic, familial, accidentally transmitted (iatro-
genic), and variant CJD [1]. The Heidenhain variant describes
any case of CJD, although it is mainly associated with the
sporadic form, in which visual symptoms are signiﬁcant in the
early stages [2]. This variant should be considered part of the
differential diagnosis involving patients presenting withand Faculty of Health Studies, University of Pardubice, 44 Kyjevská,
p. z o.o. All rights reserved.
Fig. 1 – MRI findings: absence of noticeable hippocampal and temporal atrophy in FLAIR sequences (A); visible occipital and
frontal cortical hyperintensities with a normal signal in the basal ganglia in diffusion-weighted imaging (DWI) (B).
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Heidenhain variant can be deﬁnitively diagnosed using clinical
history, EEG, brain MRI, presence of protein 14-3-3, and
postmortem brain pathological ﬁndings [3].
2. Case report
A 71-year old man, previously healthy and very active, was
admitted to the neurological department due to visual
disturbance, eye ﬁeld defects, and gait difﬁculties progressing
over one week.
The patient presented having to use two trekking poles to
stabilize his gait, which was subject to lateropulsion to the
right side. On admission, a perimeter defect was found in the
left lower quadrant along with paleocerebellar and left-sided
neocerebellar symptoms and binocular vertical diplopia,
which worsened while looking to the left. At this time, the
laboratory analysis and brain MRI were unremarkable. After 10
days, the patient was discharged with only a mild walking
imbalance and left sided hemianopia. Since the patient had
recently been diagnosed with hypertension, we attributed his
clinical manifestations to probable cerebrovascular circulation
impairment.
After one month, the patient was readmitted with
progressive and severe visual disturbances and instability
(walking was only possible with a walker). The patient
described metamorphopsia (visual foggy day combined with
visual snow, seeing two oblique pictures as being parallel,
distortion of pictures, and mirroring). We observed signiﬁcant
psychomotor slowing, apathy, decreased verbal ﬂuency,
signiﬁcant perseveration of motor tasks and words, and
grasping. Left-sided hemianopia with neglect, visual and color
agnosia, bilateral direct optic ataxia, simultagnosia, and
dressing apraxia were also present.
MRI DWI (diffusion-weighted imaging) showed cortical
hypersignals in the parietal and occipital lobes (mainly on the
right side) (Fig. 1). EEG showed temporal and occipital sharpwaves with a tendency to generalize over a slowed back-
ground. Ophthalmological examination revealed worsening of
the left-sided hemianopia with progression to the right side
and to central retinal regions. Cerebrospinal ﬂuid showed
borderline hyperproteinorhachia (0.7 g/L) with positive protein
14-3-3, and very high levels of tau protein (>1200 pg/mL);
cytology was normal and inﬂammatory and paraneoplastic
parameters (onconeural antibodies, neurotropic viruses, panel
of limbic encephalitides) were negative.
During the following weeks, the patient's mobility pro-
gressively worsened, resulting in mixed hypertonus that was
mainly limited to the upper extremities with mainly left sided
rigidity, hyperreﬂexia, startle myoclonus, muscle weakness,
and ataxia. Visual hallucinations were progressive (struc-
tured images of persons and animals produced signiﬁcant
emotional affects). Cognitive and motor impairment rapidly
led to severe dementia and increased difﬁculty in walking,
respectively.
The patient was ﬁnally bedridden as a result of myoclonus,
extrapyramidal rigidity, and akinetic mutism. He died from
bronchopneumonia about 6 months after the onset of
symptoms.
Neuropathological, immunohistochemical, neuro-immu-
nological, and molecular genetic examinations deﬁnitively
conﬁrmed the ﬁnal diagnosis: the patient met the criteria for
sporadic Creutzfeldt–Jakob disease, MM1 subtype. Spongiform
dystrophy and numeric atrophy of neuronal structures
accompanied by isomorph reactive astrogliosis was apparent
in cortical and subcortical structures (Fig. 2A and B).
Immunohistochemistry, which was positive for two mono-
clonal antibodies against the prion protein, was characterized
by diffuse synaptic positivity. Nevertheless, accented periva-
cuolar, so-called ‘‘patchy’’ positivity was also seen locally.
More prominent impairment of the occipital cortex, including
the optic region, offered a morphological background for a
clinical diagnosis of Heidenhain variant of CJD (Fig. 2C). As an
accessory neuropathological ﬁnding, deposits of the hyper-
phosphorylated form of tau protein were found in the
Fig. 2 – Neuropathology: spongiform encephalopathy of different severity seen in the striatum (A) and cerebellum (B) in
standard HE staining (original magnification 100T and 200T). Immunohistochemical positivity of pathological deposits of
prion protein in the primary visual cortex (C) using monoclonal anti-PrP antibody clone 6H4 (original magnification 200T)
and pathological deposits of hyperphosphorylated tau protein in the hippocampus (D) using monoclonal anti-tau antibody
clone AT8 (original magnification 100T).
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age related tauopathy (PART) (Fig. 2D).
3. Discussion
Our patient initially presented with visual disturbances and
gait instability that rapidly progressed to dementia with
rigidity, spasticity, and myoclonus. Our neuropathological
examination conﬁrmed sporadic Creutzfeldt–Jakob disease.
Clinical manifestations of metamorphopsia, hemianopia, and
Balint's syndrome (visual ataxia, simultagnosia, and gaze
apraxia) correlated with MRI and neuropathological ﬁndings of
signiﬁcant posterior cortical involvement, which was highly
suggestive of the Heidenhain variant of CJD. This in turn
explained the early deposits of prions in the occipital cortex.
Moreover, concomitant hyperphosphorylated tau deposits,
mainly in hippocampal areas, which met the neuropathologi-
cal criteria for primary age-related tauopathy (PART), were an
interesting accessory ﬁnding.
The Heidenhain variant mainly affects the occipital lobe,
producing visual disturbances as well as decreases in visual
acuity, metamorphopsia, dyschromatopsia, visual agnosia,
homonymous hemianopia, palinopsia, or micropsia, and even
cortical blindness [2].The cognitive proﬁle in CJD is non-speciﬁc, with a mixture
of cortical and subcortical features. In a recent study of 40
patients with CJD (conﬁrmed post mortem), early manifesta-
tions involved the frontal and parietal lobes [4]. Executive
dysfunction and speech expression were the ﬁrst to be
affected, followed by parietal lobe impairment (visuospatial
impairment and apraxia); semantic memory and processing
were relatively preserved. In our patient, early visual mani-
festations were consistent with severe neuronal cell loss in the
posterior areas of the brain, which was conﬁrmed on post
mortem (Fig. 2C). With disease progression, severe frontal lobe
signs developed, however, memory functions were less
affected, in correlation with absent signal increase or atrophy
in the mesiotemporal cortex on MRI (Fig. 1A).
The MRI is a valuable tool since it identiﬁes features that are
highly speciﬁc for CJD. According to a multicenter collabora-
tion for amending clinical diagnostic criteria, MRI ﬁndings of
either two cortical regions or both the caudate nucleus and
putamen on DWI or FLAIR had high sensitivity and speciﬁcity
in diagnosing sporadic CJD. In the Heidenhain variant, DWI
and FLAIR can show prominent cortical hyperintensities in the
occipital lobes but not in the basal ganglia [3]. In our patient,
similar ﬁndings were present (Fig. 1B).
In a recent study [1], only 5% of neuropathologically
conﬁrmed CJD cases were identiﬁed as the Heidenhain variant.
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MM1 subgroup.
The pathological accumulation of hyperphosphorylated
tau protein in neurons and astrocytes is common in the aging
brain. Recently, these conditions have been characterized as
primary age-related tauopathy (PART) and, more recently,
aging-related tau astrogliopathy (ARTAG) [5]. Despite many
neuropathologically based postmortem studies, there is still
little evidence regarding clinical correlates of either neuronal
or astroglial age-related tau pathology. Moreover, various
forms of tau pathology may coexist in the same brain affected
by other neurodegenerations and might reﬂect different
pathogenic processes; Kovacs recently described the presence
of PART in 69.3% of neuropathologically proven CJD cases [6].
In our patient, however, the clinical relevance of hyperpho-
sphorylated tau protein deposits remains uncertain, at least
in the context of rapidly progressive dementia associated
with CJD.
4. Conclusion
The Heidenhain variant of Creutzfeldt–Jakob disease is a very
rare subtype of a rare disorder; nonetheless, it should be
considered in cases with prominent visual disturbances. All
atypical cases of neurodegenerative disorders can be veriﬁed
using systematic and standardized neuropathological inves-
tigations.
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